358 related articles for article (PubMed ID: 16936473)
21. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
Tardif JC; Ponikowski P; Kahan T;
Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
[TBL] [Abstract][Full Text] [Related]
22. Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease.
Chaitman BR; Sano J
Clin Cardiol; 2007 Feb; 30(2 Suppl 1):I25-30. PubMed ID: 18373327
[TBL] [Abstract][Full Text] [Related]
23. [Ivabradine (Procoralan)].
Lancellotti P
Rev Med Liege; 2008 Apr; 63(4):220-4. PubMed ID: 18575078
[TBL] [Abstract][Full Text] [Related]
24. Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.
Werdan K; Ebelt H; Nuding S; Höpfner F; Hack G; Müller-Werdan U
Clin Res Cardiol; 2012 May; 101(5):365-73. PubMed ID: 22231643
[TBL] [Abstract][Full Text] [Related]
25. Ivabradine: a selective If current inhibitor in the treatment of stable angina.
Andrikopoulos G; Dasopoulou C; Sakellariou D; Tzeis S; Koulouris S; Kranidis A; Kappos K; Manolis AS
Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):277-82. PubMed ID: 18221092
[TBL] [Abstract][Full Text] [Related]
26. Heart rate reduction by pharmacological If current inhibition.
Cargnoni A; Ceconi C; Stavroula G; Ferrari R
Adv Cardiol; 2006; 43():31-44. PubMed ID: 16936470
[TBL] [Abstract][Full Text] [Related]
27. Angina: Ivabradine for treatment of stable angina pectoris.
de Silva R; Fox KM
Nat Rev Cardiol; 2009 May; 6(5):329-30. PubMed ID: 19377492
[TBL] [Abstract][Full Text] [Related]
28. [Antianginal efficacy of ivabradine in a very old patient with aortic stenosis: effects on cardiac output and transvalvular aortic gradients].
Nervo E; Menditto E; Taglieri C; Lombardo E; Piccolo S; Feola M
G Ital Cardiol (Rome); 2010 Sep; 11(9):699-702. PubMed ID: 21348187
[TBL] [Abstract][Full Text] [Related]
29. Heart rate reduction in heart failure: ivabradine or beta blockers?
Guglin M
Heart Fail Rev; 2013 Jul; 18(4):517-28. PubMed ID: 22972475
[TBL] [Abstract][Full Text] [Related]
30. [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists].
Hanai Y; Mita M; Hishinuma S; Shoji M
Yakugaku Zasshi; 2010 Nov; 130(11):1549-63. PubMed ID: 21048416
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.
Perings S; Stöckl G; Kelm M;
Adv Ther; 2016 Sep; 33(9):1550-64. PubMed ID: 27432382
[TBL] [Abstract][Full Text] [Related]
32. Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.
Werdan K; Ebelt H; Nuding S; Höpfner F; Stöckl G; Müller-Werdan U
Adv Ther; 2015 Feb; 32(2):120-37. PubMed ID: 25687888
[TBL] [Abstract][Full Text] [Related]
33. Rate control with ivabradine: angina pectoris and beyond.
Parakh N; Bhargava B
Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
[TBL] [Abstract][Full Text] [Related]
34. Ivabradine: pharmacodynamic aspects of its clinical use.
Stieber J
Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
[TBL] [Abstract][Full Text] [Related]
35. [The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
Ageev FT; Makarova GV; Patrusheva IF; Orlova IaA
Kardiologiia; 2010; 50(10):22-6. PubMed ID: 21118175
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic effects of I(f) blockade: evidence and perspective.
Borer JS
Pharmacol Res; 2006 May; 53(5):440-5. PubMed ID: 16621590
[TBL] [Abstract][Full Text] [Related]
37. Heart rate reduction: a potential target for the treatment of myocardial ischaemia.
Danchin N; Aly S
Therapie; 2004; 59(5):511-5. PubMed ID: 15648303
[TBL] [Abstract][Full Text] [Related]
38. [Ivabradine--the first selective and specific I(f) inhibitor, novel preparation for treatment of stable angina].
Belousov IuB; Erofeeva SB; Maneshina OA
Kardiologiia; 2006; 46(8):36-48. PubMed ID: 17047598
[TBL] [Abstract][Full Text] [Related]
39. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
Borer JS; Le Heuzey JY
Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
